Cargando…
Recent Advances of WEE1 Inhibitors and Statins in Cancers With p53 Mutations
p53 is among the most frequently mutated tumor suppressor genes given its prevalence in >50% of all human cancers. One critical tumor suppression function of p53 is to regulate transcription of downstream genes and maintain genomic stability by inducing the G1/S checkpoint in response to DNA dama...
Autores principales: | Meng, Xiangbing, Gao, Jason Z., Gomendoza, Sean Michael T., Li, John W., Yang, Shujie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520942/ https://www.ncbi.nlm.nih.gov/pubmed/34671620 http://dx.doi.org/10.3389/fmed.2021.737951 |
Ejemplares similares
-
Combination of Proteasome and Histone Deacetylase Inhibitors Overcomes the Impact of Gain-of-Function p53 Mutations
por: Meng, Xiangbing, et al.
Publicado: (2018) -
Mdm2 inhibition confers protection of p53-proficient cells from the cytotoxic effects of Wee1 inhibitors
por: Li, Yizhu, et al.
Publicado: (2015) -
WEE1 Inhibitor: Clinical Development
por: Kong, Anthony, et al.
Publicado: (2021) -
Recent Advances in p53
por: D’Orazi, Gabriella
Publicado: (2021) -
SETD8(C302R) Mutation Revealed from Myofibroblastoma‐Discordant Monozygotic Twins Leads to p53/p21 Deficit and WEE1 Inhibitor Sensitivity
por: Li, Miao, et al.
Publicado: (2020)